Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

Predictive Factors for Retreatment after Intravitreal Ranibizumab Injection to Treat Type 1 Retinopathy of Prematurity: Su Hwan Park, Iksoo Byon, Han Jo Kwon; J Korean Ophthalmol Soc. 2023;64(9):793-802. Published online September 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.9.793; Full text PubReader ePub PDF

Comparison of Intravitreal Bevacizumab and Ranibizumab Injections in Aggressive and Type 1 Retinopathy of Prematurity: Kyumin Kang, Ji Hye Jang; J Korean Ophthalmol Soc. 2023;64(9):784-792. Published online September 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.9.784; Full text PubReader ePub PDF

Course of Neovascular Age-related Macular Degeneration that Showed Limited Response to Both Ranibizumab and Aflibercept: Jeong Seop Yun, Chul Gu Kim, Jong Woo Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2023;64(4):313-322. Published online April 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.4.313; Full text PubReader ePub PDF

Case Reports

Recurrent Idiopathic Choroidal Neovascularization in an Adolescent: Hayoung Lee, Jaehyuk Lee, Jongwon Moon; J Korean Ophthalmol Soc. 2023;64(2):158-163. Published online February 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.2.158; Full text PubReader ePub PDF

Original Articles

Intraocular Cytokine Changes in Patients with Polypoidal Choroidal Vasculopathy Treated with Ranibizumab: Youna Choi, So Hee Kim, Seung Kwon Choi et al.; J Korean Ophthalmol Soc. 2022;63(2):166-174. Published online February 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.2.166; Full text PubReader ePub PDF

Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration: Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(8):1076-1083. Published online August 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.8.1076
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

One-year Outcomes of a Treat-and-extend of Ranibizumab for Naive Exudative Age-related Macular Degeneration: Retrospective Analysis: Young-Je Choi, Woong-Sun Yoo, Yong-Wun Cho, Yu-Jin Choi, In Young Chung; J Korean Ophthalmol Soc. 2021;62(7):939-947. Published online July 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.7.939; Full text PubReader ePub PDF

Status of Usage of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration.: Songhee Cho, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(8):758-764. Published online August 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.8.758
Web of Science 2 Crossref 4; PDF

Intravitreal Injection of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration: a Systematic Review.: Min Joo Kang, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(8):748-757. Published online August 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.8.748; PDF

Budget Impact Analysis of Anti-vascular Endothelial Growth Factor in Patients with Diabetic Macular Edema.: Jangmi Yang, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(7):667-675. Published online July 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.7.667
Web of Science 1 Crossref 3; PDF

Use of Anti-vascular Endothelial Growth Factors for Diabetic Retnopathy: National Health Insurance Claims Data.: Songhee Cho, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(7):661-666. Published online July 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.7.661
Web of Science 2 Crossref 9; PDF

Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept.: Tae Kyu Moon, Jun Young Ha, Mi Sun Sung, Sang Woo Park; J Korean Ophthalmol Soc. 2019;60(4):362-368. Published online April 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.4.362; PDF

Prevalence of Exudative Age-related Macular Degeneration and Projections of the Cost of Ranibizumab in Korea.: Sunyoung Ryu, Dong Wook Kim, Tyler Hyungtaek Rim, Eun Jee Chung, Jiwon Kim; J Korean Ophthalmol Soc. 2019;60(3):253-260. Published online March 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.3.253
Web of Science 2 Crossref 4; PDF

Meta-analysis of Intravitreal Injection of Anti-vascular Endothelial Growth Factors for Diabetic Macular Edema.: Hajin Tchoe, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(2):144-151. Published online February 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.2.144; PDF

Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration.: In Ho Lee, Jae Jung Lee, Han Jo Kwon, Sung Who Park, Ji Eun Lee; J Korean Ophthalmol Soc. 2019;60(1):40-46. Published online January 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.1.40
Web of Science 2 Crossref 4; PDF

Volume 65, No. 4

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

Impact Factor

0.1

MOST VIEWED MOST CITED

4,471	Contact Lens-induced Acute Red Eye
5,896	Clinical Results of Cataract Surgery Using the ARTIS ® PL E Intraocular Lens
2,727	Two Cases of Cataract after COVID-19 mRNA Vaccine Injection
1,666	Clinical Outcomes of ATOS-mediated SmartSight Lenticule Extraction
994	Novel Method Measuring Conjunctival Microvascular Blood Flow Velocity by Zoom-lens, Ultra-high-speed Camera Attached Slit-lamp Biomicroscope

Cited By 3	Clinical Results of Cataract Surgery Using the ARTIS ® PL E Intraocular Lens
Cited By 2	Comparison of Anterior Segment Measurements between Scheimpflug-Placido Camera and New Swept-source Optical Coherence Tomography
Cited By 2	Interocular Difference of Axial Length, Anterior Chamber Depth, Keratometry, Corneal Astigmatism According to Axial Length
Cited By 2	Impact of Social Distancing and Personal Hygiene on the Prevalence of Epidemic Keratoconjunctivitis during the COVID-19 Pandemic
Cited By 2	Clinical Benefits of Amniotic Membrane Contact Lens

Editorial Office: SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520 Fax: +82-2-583-6521 E-mail: kos08@ophthalmology.org

Copyright © 2024 by Korean Ophthalmological Society.

prev

next